Purpose-To identify the demographic and clinical characteristics, along with the frequency, of neoplastic masquerade syndromes in a tertiary uveitis clinic. Design-A retrospective observational cohort.Methods-Demographic and clinical data on all patients presenting to the National Eye Institute (NEI) with uveitis between 2004-2012 were used to compare neoplastic masquerade syndromes and uveitis.Results-A total of 853 patients presenting with uveitis were identified. Of these, 21 (2.5%) were diagnosed with neoplastic masquerade syndromes. The average age at presentation of masquerade syndrome patients was 57 years (median: 55, range: 38-78), for uveitis 42 years (median: 43, range: 3-98) (p=0.0003). There were 48% females in the masquerade syndromes group, compared with 59% females in the uveitis group. African American patients represented 9% of the masquerade syndrome patients and 36% of uveitis patients (p=0.01). Mean worse eye visual acuity was 0.89 (20/160) in neoplastic masquerade syndromes, and 0.66 (20/100) in the uveitis group (p=0.21). Ninety percent of masquerade syndrome patients had posterior inflammation, compared with 63% of uveitis patients (p=0.006). Forty-eight percent of the masquerade syndrome patients had unilateral disease, compared with 27% of the uveitis patients (p=0.04). Conclusion-Patientswith neoplastic masquerade syndromes were more likely to be older, male, or non-African American and to have posterior segment inflammation and unilateral disease. Patients with masquerade syndromes also had worse visual acuity than did uveitis patients. These differences in clinical characteristics may help raise the suspicion for neoplastic masquerade syndromes.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.